2 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 3 Phase 2, 2 Phase 1, 2 Phase 3, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Recruiting 1 |
Follow Pediatric AML: new trials by email Literature Review of Pediatric AML trials Research Report on Pediatric AML
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia sonrotoclax, Azacitidine, Inotuzumab ozogamicin - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 / Phase 2 | Not yet recruiting | BeOne Medicines | 30 | 2026-12-01 | 2026-10-26 |
| UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML Idarubicin Hydrochloride, Fludarabine, Cytarabine (Ara-C) - Acute Myeloid Leukemia, Pediatric AML | Early Phase 1 | Recruiting | Baylor College of Medicine | 36 | 2025-10-22 | 2026-08-24 |
| Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children Cladribine, G-CSF, Cytarabine - Leukemia, Monocytic, Acute, Pediatric AML | Phase 2 / Phase 3 | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 43 | 2021-12-01 | 2023-07-27 |
| A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) PEG- BCT-100 - Cancer, Pediatric Solid Tumor | Phase 1 / Phase 2 | Completed | University of Birmingham | 49 | 2018-08-28 | 2022-09-02 |
| Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia ARM A: Active Comparator Drug, ARM B: Blocks Therapy Drug - AML, Pediatric AML | Phase 3 | Completed | Grupo Argentino de Tratamiento de la Leucemia Aguda | 258 | 2007-08-01 | 2024-01-18 |
Leukemia, Myeloid, Acute (2) · Neoplasms (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Burkitt Lymphoma (1) · Leukemia, Monocytic, Acute (1) · Neoplasm, Residual (1) · Recurrence (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia (4) · Neoplasms by Histologic Type (4) · Leukemia, Myeloid (3) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · DNA Virus Infections (1) · Disease Attributes (1)
Cytarabine (2) · Idarubicin (2) · Azacitidine (1) · BCT-100 (1) · Cladribine (1) · Dexamethasone (1) · Etoposide (1) · Granulocyte Colony-Stimulating Factor (1) · Inotuzumab Ozogamicin (1) · Mitoxantrone (1) · Sorafenib (1) · asparaginase erwinia chrysanthemi recombinant (1) · fludarabine (1) · venetoclax (1)
Baylor College of Medicine (1) · BeOne Medicines (1) · Grupo Argentino de Tratamiento de la Leucemia Aguda (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · University of Birmingham (1)
Australia (1) · China (1) · Netherlands (1) · United Kingdom (1) · United States (1)
Alcyra Fynn, Dr. (1) · Francis J Mussai, DPhil (1)